Mumbai, Nov. 3 -- Privi Speciality Chemicals reported total income of Rs 7.73 billion for the quarter ended 30 September 2026, up 13.90% year-on-year. EBITDA rose 16.66% to Rs 2.12 billion, while profit after tax attributable to the company increased 24.61% to Rs 1.17 billion. EBITDA margin improved by 65 basis points to 27.48%.
For the first half of FY27, total income grew 16.7% to Rs 14.54 billion. EBITDA increased 17.6% to Rs 3.79 billion and profit after tax rose 29.1% to Rs 2.01 billion. Net cash from operating activities stood at Rs 3.6 billion. Net debt-to-EBITDA improved 32.1% year-on-year to 1.07x.
Privi operates seven manufacturing facilities with an installed capacity of 48,000 tonnes per annum. The company said its backward-integrated operations and manufacturing efficiencies supported performance during the period.
Expansion projects are progressing as planned and are expected to be ready for commercial operations in the second half of 2028. Its product pipeline includes Maltol, Ethyl Maltol, renewable cyclopentanone, furfural and more than 10 other speciality products, alongside over 40 products under its PRIGIV joint venture with Givaudan.
The company remains on track to reach its FY29-30 target of Rs 50 billion in revenue and more than Rs 10 billion in EBITDA. A proposed amalgamation of Privi Fine Sciences and Privi Biotechnologies with the company is expected to add green chemistry and biotechnology capabilities.
Published by HT Digital Content Services with permission from Construction World.